Skip to main content

Physiome Sciences Appoints DeLisi to Scientific Advisory Board

NEW YORK, Dec 6 - Physiome Sciences said Wednesday it had appointed Charles DeLisi, to its scientific advisory board.

DeLisi, currently director of the All University Program in Bioinformatics at Boston University, is also a member of the Los Alamos National Laboratory and chairman of the board of scientific counselors for the National Center for Biotechnology Information.

  " We are delighted that Dr. DeLisi has joined Physiome's scientific advisory board, and that we have access to his expertise in the bioinformatics and genomic fields," Jeremy Levin, Chairman and CEO of Physiome Sciences, said in a statement.

Physiome Sciences is a privately held company based in Princeton, NJ. It develops software tools, proprietary databases, and web applications for simulating life processes.

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.